The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol CT34440 is literature-poor, but the supplied UniProt mapping identifies it as the D. melanogaster gene CG14662 (ORF Dmel_CG14662; FlyBase FBgn0037291) encoding UniProt Q9VN74. Searches under CT34440, CG14662, FBgn0037291, and Q9VN74 found no conflicting same-symbol protein in another organism. Published work normally refers to this target as CG14662, not CT34440.
The strongest gene-specific evidence is a comparative-genomics study published on 12 September 2007. It lists CG14662 as a 550-amino-acid “LRR_Only” singleton with the computationally predicted architecture signal sequence–six leucine-rich repeats–transmembrane segment (“SS, 6LRR, TM”). This supports a provisional annotation as a secretory-pathway, single-pass membrane protein whose LRR-containing region probably mediates extracellular molecular recognition. It does not identify a ligand, binding partner, catalytic reaction, transported substrate, tissue, phenotype, or signaling pathway. No direct experimental functional characterization or substantive 2023–2024 update was found. (dolan2007theextracellularleucinerich pages 8-10)
| Topic | Finding | Evidence type | Confidence | Key limitation |
|---|---|---|---|---|
| Identity | CT34440, CG14662, Dmel_CG14662, FlyBase FBgn0037291, and UniProt Q9VN74 identify the target Drosophila melanogaster protein. | User-provided UniProt mapping; CG14662 independently appears as a fly protein in Dolan et al. (dolan2007theextracellularleucinerich pages 8-10) | High | CT34440 is rarely used in literature; identity relies primarily on the supplied UniProt record rather than an independently retrieved cross-reference page. |
| Protein length | The protein was reported as 550 amino acids. (dolan2007theextracellularleucinerich pages 8-10) | Comparative-genomics catalog | High for the protein model used in 2007 | Current isoform models or sequence revisions were not independently verified. |
| Domain architecture | Predicted architecture: signal sequence, six leucine-rich repeats, and one transmembrane segment (SS, 6LRR, TM); classified as an LRR_Only singleton. (dolan2007theextracellularleucinerich pages 8-10) |
Computational sequence/topology analysis | Moderate | Predictions are not experimental demonstrations of domain boundaries, membrane insertion, or orientation. |
| Localization/topology | The architecture is most consistent with entry into the secretory pathway and a single-pass, likely type-I membrane protein bearing an extracellular LRR region. (dolan2007theextracellularleucinerich pages 8-10) | Structure-based inference | Moderate–low | No gene-specific microscopy, biochemical fractionation, surface labeling, or topology experiment was found. |
| Probable molecular role | LRRs support a general molecular-recognition or protein-interaction role, potentially at the cell surface. (dolan2007theextracellularleucinerich pages 8-10, dolan2007theextracellularleucinerich pages 1-2) | Domain-based inference | Low | LRRs occur in many unrelated systems and do not identify a ligand, binding partner, receptor family, or biological process. |
| Enzymatic or transport function | No catalytic reaction, cofactor, enzymatic substrate, transporter activity, or transported substrate is known. | Absence of gene-specific functional evidence in the sources reviewed | High confidence that none is currently established | Absence of published evidence does not prove that the protein lacks such activity. |
| Signaling pathway and ligand | No ligand, downstream effector, or signaling-pathway membership has been established; the LRR annotation does not justify assignment to Toll or another pathway. (dolan2007theextracellularleucinerich pages 1-2, dolan2007theextracellularleucinerich pages 10-12) | Literature assessment | High | Undiscovered or unpublished interactions remain possible. |
| Phenotype and biological process | No precise loss-of-function, gain-of-function, rescue, or biochemical phenotype was found, so no biological process can presently be assigned with confidence. | Literature assessment | High | High-throughput resources not represented in the retrieved literature may contain preliminary observations. |
| 2024 exosome study | CG14662 was mentioned only as an unannotated neighboring gene near the CG2022 GWAS locus; it was not one of the reported top associated genes and was not experimentally tested. (takashima2024characterizingmaledrosophila pages 21-28) | Genomic-proximity observation in a dissertation | High | Proximity to an associated locus neither establishes association nor implicates CG14662 in exosome biogenesis, secretion, or reproduction. |
Table: Evidence hierarchy for CT34440/CG14662/Q9VN74, separating reported sequence architecture from biological inference. It highlights that localization and interaction roles remain predictions and that no specific ligand, pathway, activity, or phenotype is established.
The target should be tracked using the following identifier set:
The peer-reviewed literature independently confirms that CG14662 is a fly protein and reports a 550-aa model with LRR-containing architecture. No retrieved paper used CT34440 to describe a different protein. Accordingly, there is no basis for redirecting the analysis to another gene, organism, or similarly named protein. (dolan2007theextracellularleucinerich pages 8-10)
LRRs are repeated structural motifs that commonly create curved interaction surfaces for protein–protein or protein–ligand recognition. They are architectural interaction modules, not catalytic motifs. Across animals, extracellular LRR proteins participate in diverse systems—including adhesion, receptor biology, immunity, and neural development—but domain presence alone cannot identify which, if any, of these processes applies to CG14662. The broader comparative survey identified 66 extracellular-LRR proteins in fly, illustrating both the abundance and functional diversity of this class. (dolan2007theextracellularleucinerich pages 1-2)
CG14662 was classified specifically in the survey’s LRR_Only singleton category, rather than with Toll-related proteins or proteins carrying immunoglobulin/FN3 domains. Its reported architecture was:
These were computational consensus predictions derived from sequence, motif, signal-peptide, and topology analyses—not biochemical measurements. The paper did not report an LRR N-terminal or C-terminal cap for CG14662, although failure to predict such caps does not prove their absence. (dolan2007theextracellularleucinerich pages 8-10, dolan2007theextracellularleucinerich pages 16-18)
The combined signal sequence and transmembrane segment are most consistent with entry into the endoplasmic-reticulum/secretory pathway and membrane anchoring. A reasonable working model is therefore a single-pass, likely type-I membrane protein, with the LRR-rich region exposed to the lumen during biosynthesis and ultimately to the extracellular space at the plasma membrane. This orientation remains an inference: no CG14662-specific surface labeling, protease protection, glycosylation mapping, fractionation, or microscopy experiment was found. (dolan2007theextracellularleucinerich pages 8-10)
No primary molecular function has been established experimentally.
The most defensible molecular annotation is therefore: “predicted single-pass membrane LRR protein, potentially involved in extracellular molecular recognition.” It should not be annotated as a Toll receptor, innate-immune component, neural guidance receptor, enzyme, or transporter without additional evidence. The source explicitly places CG14662 among LRR-only singletons, and the general survey cautions that architecture and clustering do not establish a specific pathway. (dolan2007theextracellularleucinerich pages 8-10, dolan2007theextracellularleucinerich pages 10-12)
The predicted signal peptide and transmembrane helix support localization somewhere along the secretory pathway and/or plasma membrane. The probable functional face of the protein is extracellular or organelle-luminal because that is where the LRR region would reside under the type-I topology model. Nevertheless, no direct evidence identifies the cell type, tissue, membrane compartment, apical/basal distribution, or developmental stage in which endogenous CG14662 protein operates. (dolan2007theextracellularleucinerich pages 8-10)
It is therefore appropriate to distinguish:
No signaling or biochemical pathway can currently be assigned with confidence. LRR proteins as a superfamily have roles in innate immunity, inflammation, development, and neuronal connectivity, but those are broad class-level observations and cannot be transferred to CG14662 without gene-specific expression, interaction, or phenotype data. In particular, the LRR annotation does not justify assignment to Toll signaling. (dolan2007theextracellularleucinerich pages 1-2, dolan2007theextracellularleucinerich pages 10-12)
No precise loss-of-function, overexpression, rescue, biochemical, or interaction phenotype was found. Consequently, claims that CG14662 controls immunity, nervous-system development, cell adhesion, reproduction, or vesicle biology would currently be speculative.
The only located 2024 source mentioning CG14662 was a dissertation GWAS of male accessory-gland extracellular-vesicle abundance. The study examined 35 Drosophila Genetic Reference Panel lines, analyzed 1,337,199 SNPs, used a conservative threshold of approximately 7.3 × 10⁻⁷, and reported 12 SNPs passing that cutoff. CG14662 was not identified as one of those top gene hits; it was mentioned solely because it lies near CG2022, a locus containing an associated SNP. The author described CG14662 as unannotated and generated no expression, localization, knockout, or mechanistic evidence for it. (takashima2024characterizingmaledrosophila pages 21-28)
Accordingly, that study does not establish that CG14662 regulates exosome biogenesis, secretion, male reproduction, or accessory-gland biology. Genomic proximity is useful for nominating follow-up candidates, but it cannot identify the causal gene without fine mapping or functional validation. (takashima2024characterizingmaledrosophila pages 21-28)
No gene-specific 2023 publication, 2023–2024 biochemical study, structure, validated interactome, or mechanistic functional analysis was retrieved. Thus, the lack of a recent mechanistic update is itself an important conclusion: CG14662 remains functionally uncharacterized despite its long-standing architectural annotation.
There is no established applied use for CG14662 in biotechnology, medicine, pest control, or diagnostics. At present its practical value is principally as:
These are research opportunities, not demonstrated applications.
The highest-value validation sequence would be:
CG14662/CT34440 (Q9VN74) is best described as an uncharacterized D. melanogaster 550-aa LRR-only protein with a predicted signal sequence, six LRRs, and one transmembrane segment. Its probable role is extracellular molecular recognition by a single-pass membrane protein, but this remains an architectural inference. No ligand, catalytic activity, transporter substrate, signaling pathway, precise cellular location, biological process, or phenotype has been established. (dolan2007theextracellularleucinerich pages 8-10)
References
(dolan2007theextracellularleucinerich pages 8-10): Jackie Dolan, Karen Walshe, Samantha Alsbury, Karsten Hokamp, Sean O'Keeffe, Tatsuya Okafuji, Suzanne FC Miller, Guy Tear, and Kevin J Mitchell. The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics, 8:320-320, Sep 2007. URL: https://doi.org/10.1186/1471-2164-8-320, doi:10.1186/1471-2164-8-320. This article has 223 citations and is from a peer-reviewed journal.
(dolan2007theextracellularleucinerich pages 1-2): Jackie Dolan, Karen Walshe, Samantha Alsbury, Karsten Hokamp, Sean O'Keeffe, Tatsuya Okafuji, Suzanne FC Miller, Guy Tear, and Kevin J Mitchell. The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics, 8:320-320, Sep 2007. URL: https://doi.org/10.1186/1471-2164-8-320, doi:10.1186/1471-2164-8-320. This article has 223 citations and is from a peer-reviewed journal.
(dolan2007theextracellularleucinerich pages 10-12): Jackie Dolan, Karen Walshe, Samantha Alsbury, Karsten Hokamp, Sean O'Keeffe, Tatsuya Okafuji, Suzanne FC Miller, Guy Tear, and Kevin J Mitchell. The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics, 8:320-320, Sep 2007. URL: https://doi.org/10.1186/1471-2164-8-320, doi:10.1186/1471-2164-8-320. This article has 223 citations and is from a peer-reviewed journal.
(takashima2024characterizingmaledrosophila pages 21-28): Y Takashima. Characterizing male drosophila exosome number variation and its role in reproduction. Unknown journal, 2024.
(dolan2007theextracellularleucinerich pages 16-18): Jackie Dolan, Karen Walshe, Samantha Alsbury, Karsten Hokamp, Sean O'Keeffe, Tatsuya Okafuji, Suzanne FC Miller, Guy Tear, and Kevin J Mitchell. The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics, 8:320-320, Sep 2007. URL: https://doi.org/10.1186/1471-2164-8-320, doi:10.1186/1471-2164-8-320. This article has 223 citations and is from a peer-reviewed journal.